Article Details

SGLT2 Inhibitors Are Gaining Momentum in Chronic and Diabetic Kidney Disease ... - PR Newswire

Retrieved on: 2022-03-09 04:41:40

Tags for this article:

Click the tags to see associated articles and topics

SGLT2 Inhibitors Are Gaining Momentum in Chronic and Diabetic Kidney Disease ... - PR Newswire. View article details on hiswai:

Excerpt

Physician-reported and patient audit data reveal increased real world use of SGLT2 inhibitors (AstraZeneca's Farxiga, Vifor/Janssen's Invokana, ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up